Clinical pharmacology of old age syndromes.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.0306-5251.2003.01877.XPMID 12919174PMCID PMC1884351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles.

  2006cited by this paper
• Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment.

  2006cited by this paper
• A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate.

  2005cited by this paper
• A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium

  2005cited by this paper
• Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers

  2004cited by this paper
• Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment.

  2004cited by this paper
• The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

  2003cited by this paper
• Serum Concentration of Chlormethiazole and Therapeutic Effect in Acute Alcohol Withdrawal Syndrome: An Open Clinical Trial

  2002cited by this paper
• The role of atypical antipsychotics in the treatment of delirium.

  2002cited by this paper
• Tolterodine: As effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder

  2002cited by this paper
• The role of antipsychotics in treating delirium

  2002cited by this paper
• Efficacy, Safety, and Tolerability of Extended‐Release Once‐Daily Tolterodine Treatment for Overactive Bladder in Older versus Younger Patients

  2002cited by this paper
• Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.

  2002cited by this paper
• Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial.

  2002cited by this paper
• The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society

  2002cited by this paper
• As the occasion arises: PRN sedative orders in alcohol withdrawal treatment.

  2002cited by this paper
• A Novel Approach to the Prevention of Postoperative Delirium in the Elderly After Gastrointestinal Surgery

  2002cited by this paper
• An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients.

  2002cited by this paper
• Delirium: optimising management

  2001cited by this paper
• An open pilot trial of olanzapine for delirium in the Korean population

  2001cited by this paper
• [Use of procholinergics in the prevention of postoperative delirium in hip fracture surgery in the elderly. A randomized controlled trial].

  2001cited by this paper
• Tolterodine: A Safe and Effective Treatment for Older Patients with Overactive Bladder

  2001cited by this paper
• Practice Guidelines for the Treatment of Patients With Delirium

  2001cited by this paper
• Immunology of delirium: new opportunities for treatment and research

  2001cited by this paper
• Optimising management of delirium. Placebo controlled trials of pharmacological treatments are needed.

  2001cited by this paper
• Optimising management of delirium. Withdrawal of Droleptan (droperidol).

  2001cited by this paper
• Animal research

  2001cited by this paper
• Optimising management of delirium

  2001cited by this paper
• Optimising management of delirium. Patients with delirium should be treated with care.

  2001cited by this paper
• Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole.

  2001cited by this paper
• Anti–tumor necrosis factor therapies

  2001cited by this paper
• Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

  2001cited by this paper
• Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine

  2001cited by this paper
• Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System

  2001cited by this paper
• How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study

  2001cited by this paper
• A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate.

  2001cited by this paper
• Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.

  2001cited by this paper
• A randomized controlled trial comparing the efficacy of controlled‐release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

  2000cited by this paper
• Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies

  2000cited by this paper
• [Clinical trial to evaluate trospium chloride (Uraplex) effectiveness and tolerance in patients with detrusor instability incontinence and its impact on quality of life].

  2000cited by this paper
• [Alcohol withdrawal syndrome and its treatment].

  2000cited by this paper
• Cytokines and the brain: implications for clinical psychiatry.

  2000cited by this paper
• Low–Dose Oxybutynin for the Treatment of Urge Incontinence: Good Efficacy and Few Side Effects

  2000cited by this paper
• Dry Mouth With Conventional and Controlled‐Release Oxybutynin in Urinary Incontinence

  2000cited by this paper
• Muscle strength, functional mobility and vitamin D in older women

  2000cited by this paper
• Alcohol withdrawal and treatment

  2000cited by this paper
• Immediate‐Release Oxybutynin versus Tolterodine in Detrusor Overactivity: A Population Analysis

  2000cited by this paper
• Efficacy of trospium chloride in patients with detrusor instability: a placebo‐controlled, randomized, double‐blind, multicentre clinical trial

  2000cited by this paper
• Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery

  2000cited by this paper
• Pathogenesis of hepatic encephalopathy.

  2000cited by this paper
• Effects of a Short‐Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women

  2000cited by this paper
• Treatment of Delirium With Quetiapine.

  2000cited by this paper
• Combined Behavioral and Drug Therapy for Urge Incontinence in Older Women

  2000cited by this paper
• Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength.

  2000cited by this paper
• Low Serum Calcidiol Concentration in Older Adults with Reduced Muscular Function

  1999cited by this paper
• Practice guideline for the treatment of patients with delirium. American Psychiatric Association.

  1999cited by this paper
• Oral desmopressin for nocturnal polyuria in elderly subjects: a double‐blind, placebo‐controlled randomized exploratory study

  1999cited by this paper
• Muscle strength in the elderly: its relation to vitamin D metabolites.

  1999cited by this paper
• Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.

  1999cited by this paper
• Neural mechanisms of delirium: current hypotheses and evolving concepts.

  1999cited by this paper
• A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders.

  1999cited by this paper
• Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia – A double-blind, placebo-controlled clinical trial

  1999cited by this paper
• Complicated delirium in a cancer patient successfully treated with olanzapine.

  1999cited by this paper
• A placebo‐controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence

  1999cited by this paper
• Clinical Efficacy of Oxybutynin on Sensory Urgency as Compared with That on Motor Urgency

  1999cited by this paper
• [Alcohol withdrawal syndrome and delirium tremens. Diagnosis and therapy].

  1999cited by this paper
• Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity.

  1999cited by this paper
• Delirium in elderly patients treated with risperidone: a report of three cases.

  1998cited by this paper
• The role of glutamatergic neurotransmission in the pathophysiology of alcoholism.

  1998cited by this paper
• Pathophysiology of Delirium

  1998cited by this paper
• Identification of Medications That Cause Cognitive Impairment in Older People: The Case of Oxybutynin Chloride

  1998cited by this paper
• Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial.

  1998cited by this paper
• Relationship between age-associated endocrine deficiencies and muscle function in elderly women: a cross-sectional study.

  1998cited by this paper
• The cellular basis of bladder instability.

  1998cited by this paper
• Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation

  1998cited by this paper
• A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo.

  1998cited by this paper
• Tolterodine--a new bladder-selective antimuscarinic agent.

  1998cited by this paper
• Olanzapine in the treatment of delirium.

  1998cited by this paper
• Pathophysiology of delirium.

  1998cited by this paper
• Psychopharmacological treatment of delirium to restore mental capacity.

  1998cited by this paper
• Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder.

  1998cited by this paper
• The association of serum anticholinergic activity with delirium in elderly medical patients.

  1998cited by this paper
• Donepezil Improves Symptoms of Delirium in Dementia: Implications for Future Research

  1998cited by this paper
• Therapeutic Considerations in the Management of Agitated or Delirious Critically 111 Patients

  1998cited by this paper
• Psychosis in medical conditions: response to risperidone.

  1997cited by this paper
• Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy.

  1997cited by this paper
• Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine.

  1997cited by this paper
• Nocturnal polyuria in the elderly person.

  1997cited by this paper
• Quadriceps and Grip Strength Are Related to Vitamin D Receptor Genotype in Elderly Nonobese Women

  1997cited by this paper
• A small exploratory study of the reaction of older people to an episode of delirium.

  1997cited by this paper
• Management of acute delirium in hospitalized elderly: a process improvement project.

  1997cited by this paper
• Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.

  1997cited by this paper
• Tolterodine – a new bladder-selective antimuscarinic agent

  1997cited by this paper
• A neurologic basis for the overactive bladder

  1997cited by this paper
• Cognitive impairment in medical inpatients. I: Screening for dementia--is history better than mental state?

  1997cited by this paper
• A neurologic basis for the overactive bladder.

  1997cited by this paper
• Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial.

  1997cited by this paper
• The Prognostic Significance of Delirium in Older Hospital Patients

  1997cited by this paper
• A myogenic basis for the overactive bladder.

  1997cited by this paper
• A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance

  1997cited by this paper

• Older People and Substance Misuse

  2020cites this paper
• A literature review of the atypical antipsychotics in the management of delirium: implications for mental health liaison practice

  2010cites this paper
• Delirium and its Treatment

  2008cites this paper
• Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment.

  2006cites this paper
• Pharmacotherapeutics in Older Adults

  2006cites this paper
• Physical and chemical restraints in acute care: their potential impact on the rehabilitation of older people.

  2005cites this paper